Cargando…

Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study

AIMS/HYPOTHESIS: Serum sex hormone-binding globulin (SHBG) has been proposed to act as a hepatokine that contributes to the extrahepatic complications observed in non-alcoholic fatty liver disease (NAFLD). However, it remains uncertain whether serum SHBG mediates the association between intrahepatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Simons, Pomme I. H. G., Valkenburg, Olivier, van de Waarenburg, Marjo P. H., van Greevenbroek, Marleen M. J., Kooi, M. Eline, Jansen, Jacobus F. A., Schalkwijk, Casper G., Stehouwer, Coen D. A., Brouwers, Martijn C. G. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729158/
https://www.ncbi.nlm.nih.gov/pubmed/36114428
http://dx.doi.org/10.1007/s00125-022-05790-7
_version_ 1784845424074424320
author Simons, Pomme I. H. G.
Valkenburg, Olivier
van de Waarenburg, Marjo P. H.
van Greevenbroek, Marleen M. J.
Kooi, M. Eline
Jansen, Jacobus F. A.
Schalkwijk, Casper G.
Stehouwer, Coen D. A.
Brouwers, Martijn C. G. J.
author_facet Simons, Pomme I. H. G.
Valkenburg, Olivier
van de Waarenburg, Marjo P. H.
van Greevenbroek, Marleen M. J.
Kooi, M. Eline
Jansen, Jacobus F. A.
Schalkwijk, Casper G.
Stehouwer, Coen D. A.
Brouwers, Martijn C. G. J.
author_sort Simons, Pomme I. H. G.
collection PubMed
description AIMS/HYPOTHESIS: Serum sex hormone-binding globulin (SHBG) has been proposed to act as a hepatokine that contributes to the extrahepatic complications observed in non-alcoholic fatty liver disease (NAFLD). However, it remains uncertain whether serum SHBG mediates the association between intrahepatic lipids (IHL) and type 2 diabetes. Therefore, we studied whether, and to what extent, serum SHBG mediates the association between IHL content and type 2 diabetes. METHODS: We used cross-sectional data from the Maastricht Study (n=1554), a population-based cohort study with oversampling of individuals with type 2 diabetes. Type 2 diabetes status was assessed by oral glucose tolerance test, and IHL content was measured using 3T Dixon MRI. Mediation analyses were performed to assess the role of serum SHBG in mediating the association between IHL content and type 2 diabetes. RESULTS: IHL content was significantly associated with type 2 diabetes in women and men (OR 1.08 [95% CI 1.04, 1.14] and OR 1.12 [95% CI 1.08, 1.17], respectively). Serum SHBG significantly mediated the association between IHL content and type 2 diabetes. The contribution of serum SHBG was higher in women (OR 1.04 [95% CI 1.02, 1.07]; proportion mediated 50.9% [95% CI 26.7, 81.3]) than in men (OR 1.02 [95% CI 1.01, 1.03]; proportion mediated 17.2% [95% CI 9.6, 27.6]). Repeat analyses with proxies of type 2 diabetes and adjustment for covariates did not substantially affect the results. CONCLUSIONS/INTERPRETATION: In this large-scale population-based cohort study, serum SHBG was found to be a mediator of the association between IHL content and type 2 diabetes. These findings extend our understanding of the potential mechanisms by which NAFLD is a risk factor for type 2 diabetes, and further elaborate on the role of SHBG as a hepatokine. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-022-05790-7
format Online
Article
Text
id pubmed-9729158
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-97291582022-12-09 Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study Simons, Pomme I. H. G. Valkenburg, Olivier van de Waarenburg, Marjo P. H. van Greevenbroek, Marleen M. J. Kooi, M. Eline Jansen, Jacobus F. A. Schalkwijk, Casper G. Stehouwer, Coen D. A. Brouwers, Martijn C. G. J. Diabetologia Article AIMS/HYPOTHESIS: Serum sex hormone-binding globulin (SHBG) has been proposed to act as a hepatokine that contributes to the extrahepatic complications observed in non-alcoholic fatty liver disease (NAFLD). However, it remains uncertain whether serum SHBG mediates the association between intrahepatic lipids (IHL) and type 2 diabetes. Therefore, we studied whether, and to what extent, serum SHBG mediates the association between IHL content and type 2 diabetes. METHODS: We used cross-sectional data from the Maastricht Study (n=1554), a population-based cohort study with oversampling of individuals with type 2 diabetes. Type 2 diabetes status was assessed by oral glucose tolerance test, and IHL content was measured using 3T Dixon MRI. Mediation analyses were performed to assess the role of serum SHBG in mediating the association between IHL content and type 2 diabetes. RESULTS: IHL content was significantly associated with type 2 diabetes in women and men (OR 1.08 [95% CI 1.04, 1.14] and OR 1.12 [95% CI 1.08, 1.17], respectively). Serum SHBG significantly mediated the association between IHL content and type 2 diabetes. The contribution of serum SHBG was higher in women (OR 1.04 [95% CI 1.02, 1.07]; proportion mediated 50.9% [95% CI 26.7, 81.3]) than in men (OR 1.02 [95% CI 1.01, 1.03]; proportion mediated 17.2% [95% CI 9.6, 27.6]). Repeat analyses with proxies of type 2 diabetes and adjustment for covariates did not substantially affect the results. CONCLUSIONS/INTERPRETATION: In this large-scale population-based cohort study, serum SHBG was found to be a mediator of the association between IHL content and type 2 diabetes. These findings extend our understanding of the potential mechanisms by which NAFLD is a risk factor for type 2 diabetes, and further elaborate on the role of SHBG as a hepatokine. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-022-05790-7 Springer Berlin Heidelberg 2022-09-17 2023 /pmc/articles/PMC9729158/ /pubmed/36114428 http://dx.doi.org/10.1007/s00125-022-05790-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Simons, Pomme I. H. G.
Valkenburg, Olivier
van de Waarenburg, Marjo P. H.
van Greevenbroek, Marleen M. J.
Kooi, M. Eline
Jansen, Jacobus F. A.
Schalkwijk, Casper G.
Stehouwer, Coen D. A.
Brouwers, Martijn C. G. J.
Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study
title Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study
title_full Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study
title_fullStr Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study
title_full_unstemmed Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study
title_short Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study
title_sort serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the maastricht study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729158/
https://www.ncbi.nlm.nih.gov/pubmed/36114428
http://dx.doi.org/10.1007/s00125-022-05790-7
work_keys_str_mv AT simonspommeihg serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy
AT valkenburgolivier serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy
AT vandewaarenburgmarjoph serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy
AT vangreevenbroekmarleenmj serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy
AT kooimeline serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy
AT jansenjacobusfa serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy
AT schalkwijkcasperg serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy
AT stehouwercoenda serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy
AT brouwersmartijncgj serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy